1. Home
  2. WOR vs GLPG Comparison

WOR vs GLPG Comparison

Compare WOR & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Enterprises Inc.

WOR

Worthington Enterprises Inc.

HOLD

Current Price

$55.67

Market Cap

2.8B

ML Signal

HOLD

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$33.55

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WOR
GLPG
Founded
1955
1999
Country
United States
Belgium
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.2B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
WOR
GLPG
Price
$55.67
$33.55
Analyst Decision
Buy
Buy
Analyst Count
3
2
Target Price
$59.67
$36.00
AVG Volume (30 Days)
139.7K
73.7K
Earning Date
03-16-2026
01-01-0001
Dividend Yield
1.33%
N/A
EPS Growth
N/A
N/A
EPS
1.25
N/A
Revenue
$1,153,762,000.00
N/A
Revenue This Year
$17.70
$1.73
Revenue Next Year
$5.30
$0.49
P/E Ratio
$45.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$39.05
$22.59
52 Week High
$70.91
$37.78

Technical Indicators

Market Signals
Indicator
WOR
GLPG
Relative Strength Index (RSI) 47.12 47.49
Support Level $51.36 $33.12
Resistance Level $56.48 $33.95
Average True Range (ATR) 1.28 0.63
MACD -0.26 -0.08
Stochastic Oscillator 10.02 24.43

Price Performance

Historical Comparison
WOR
GLPG

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: